Dr. Nina Niu Sanford
@NiuSanford
GI Radiation Oncologist | Boston, @Princeton, @harvardmed, now @UTSWNews in Dallas | clinical trials | buying in bulk | Tweets=own | FCOI: http://rb.gy/h
After our daughter Ceci died at 15 mo of a paraspinal tumor, we’ve been committed to supporting pediatric cancer research. We’re honored this year's Cattle Baron’s Ball will establish Ceci’s Fund through the American Cancer Society. Please share/donate💕 cattlebaronsball.com




Thank you so much!🙏 My goal is to demystify rad onc (& GI onc). Channel link is here btw. Planning for more videos to come! youtube.com/@NinaNSanfordMD
One of our stellar @ASCO LDP mentees this year, @NiuSanford @utswcancer, has put together a phenomenal series of online lectures on @YouTube (totally free!) detailing different aspects of #radonc. There is certainly some focus on GI onc, her specialty, but I think every #hemeonc…
Heading home after an incredible first session of the ASCO LDP at ASCO HQ in beautiful Old Town Alexandria. Truly grateful for the opportunity to learn alongside such brilliant colleagues and from inspiring mentors and ASCO staff. Excited for what lies ahead in the program!
Congrats @NiuSanford on @NRGOncology GI-011 activated! Tagging my #GI colleagues in #LosAngeles to support enrollment. @DaniCastilloMD @gagan_brar24 @mgfakih @DrElkhoueiry @DrJZell @pashtoonkasi
Excited to be at my first @NRGonc meeting & even more excited about the recently opened trials presented in the general #radonc ☢️ meeting! 🤗 Can’t wait to learn more in the upcoming session! @AnnKloppMD @NiuSanford
A big big thank you to our 4 great ASCO LDP mentors, who choose to dedicate an enormous amount of time & energy to this program. We appreciate all of their support! @montypal, @DrMarkham, Nasser Hanna & Piyush Srivastava 🙏

🎙️ New #ESMO Podcast – Controversies in Upper GI Cancers 📌 Radiotherapy in borderline resectable #PDAC: Evidence vs practice – when does it make sense? @NiuSanford & @BasGrootKoerkam join me to discuss a case & key trials. 🎧 Listen: open.spotify.com/episode/6NFOKd… #PancreaticCancer
Excited to be at my first @NRGonc meeting & even more excited about the recently opened trials presented in the general #radonc ☢️ meeting! 🤗 Can’t wait to learn more in the upcoming session! @AnnKloppMD @NiuSanford
Sharing more clips from our interview. Dr. D'Amico on his exercise/wellness philosophy, and practicing gratitude.
I asked Dr. D'Amico to recommend 1 fiction & 1 non-fiction book. He chose Lengthen Your Line (from Zen in the Martial Arts) & the Bible.
Congratulations to @TedHong9 on vice chair of @Harvard @BIDMChealth Radiation oncology hmfphysicians.org/ted-hong-md-na…. Listen to latest @NRGonc podcast this month on his work to improve treatment of liver cancer. open.spotify.com/episode/1rEiwZ… @lauren_henke
4.1K likes & 169K views on this post...which fails to mention the patient was also receiving standard of care 1st line "big pharma" FOLFIRINOX chemotherapy (info buried in screenshotted email)🤦🏽♀️.
NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 57 year old California man with Stage 2 Pancreatic Cancer has incredible response to 4 months of therapy Pancreatic Cancer is not only treatable...it's curable, but they don't want you to know that! 🤔 57 year old…
The core problem with present day academia is that there are great incentives for dishonesty, and great disincentives for policing dishonesty. Peer review itself is a thankless task that doesn’t advance one’s career and is not always done to the most rigorous standards. Data…
East coast bound x 2 weeks - Virginia for ASCO LDP, DC for @NRGonc, then Boston to see family/friends ✈️. And all (barely) packed into a carry-on 🧳!

Such a joy hearing Anthony share his stories, experience, and wisdom. He is truly one of a kind
Dr. D’Amico discusses his first clinical trial, RT+/- 6 mo ADT in unfavorable-risk prostate cancer (JAMA 2008). Such a great story of perseverance, ingenuity, & making the most of a situation.
Dr. D’Amico discusses his first clinical trial, RT+/- 6 mo ADT in unfavorable-risk prostate cancer (JAMA 2008). Such a great story of perseverance, ingenuity, & making the most of a situation.